Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma

doi:10.4254/wjh.v7.i3.628

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6303)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

489

WORD

197

HTML

3126

Figures (1-1)

166

Tables (1-4)

175

Sum=4153

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

862

Download

1288

Sum=2150

Mar 27, 2015 (publication date) through Jul 31, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Mar 27, 2015; 7(3): 628-632
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628

Table 4 Barcelona clinic liver cancer B substaging response rates according to mRECIST n (%)

	CR	PR	PD	SD
B1	12 (25)	29 (60.4)	3 (6.25)	3 (6.25)
B2	6 (22.2)	13 (48)	1 (3.7)	7 (26.1)
B3	1 (7.6)	4 (30.7)	1 (7.6)	7 (53.8)
B4	-	-	1 (50)	1 (50)

CR: Complete response; PR: Partial response; PD: Progressive disease; SD: Stable disease.

Citation: Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/628.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i3.628